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cDepartment of Radiology, Jean-Talon Hospital, University of Montreal Hospital Center, Montreal, Quebec, CanadaAbstractPurpose: The rate of unsatisfactory samples from ultrasound-guided fine-needle aspirations of thyroid nodules varies widely in the literature.
We aimed to evaluate our thyroid ultrasound-guided fine-needle aspiration biopsy technique in the absence of on-site microscopic exami-
nation by a pathologist; determine factors that affect the adequacy rate, such as the number of needle passes and needle size; compare our
results with the literature; and establish an optimal technique.
Materials and Methods: We performed a retrospective review of cytopathology reports from 252 consecutive thyroid ultrasound-guided
fine-needle aspiration biopsies performed by a radiologist between 2005 and 2010 in our hospital’s radiology department. Sample
adequacy, the number of needle passes, and needle size were determined. There was an on-site cytologist who prepared slides immediately
after fine-needle aspiration but no on-site microscopic assessment of sample adequacy to guide the number of needle passes that should be
performed. Cytopathology biopsy reports were classified as either unsatisfactory or satisfactory samples for diagnosis; the latter consisted of
benign, malignant, and undetermined diagnoses.
Results: Seventy-seven biopsies were performed with 1 needle pass, 124 with 2 needle passes, and 51 with 3 needle passes. The rates of
unsatisfactory biopsies were 33.8%, 23.4% (odds ratio [OR] 0.599 [95% confidence interval {CI}, 0.319-1.123]; P ¼ .110), and 13.7% (OR
0.312 [95% CI, 0.124-0.788]; P ¼ .014), respectively.
Conclusion: In a hospital in which there is no on-site pathologist, a 3-pass method increases the specimen satisfactory rate by 20% compared
with 1 pass, achieves similar rates to the literature, and provides a basis for further improvement of our practice.ResumeObjet : La documentation fait etat de taux d’echantillons insatisfaisants tres variables en ce qui concerne la cytoponction sous echoguidage
de nodules thyro€ıdiens. Notre objectif visait a evaluer la technique de cytoponction sous echoguidage de la thyro€ıde que nous employons
lorsqu’aucun pathologiste n’effectue d’examen microscopique sur les lieux, a definir les facteurs qui influent sur le taux de succes,
notamment le nombre de passages et la taille de l’aiguille, a comparer nos resultats a ceux presentes dans la documentation et a etablir une
technique optimale.
Materiel et methode : Nous avons effectue un examen retrospectif du rapport de cytopathologie de 252 cytoponctions sous echoguidage de la
thyro€ıde consecutives, realisees par les radiologistes du service de radiologie de notre ho^pital entre 2005 et 2010. La validite des echantillons, le
nombre de passages et la taille de l’aiguille ont ete determines. Le cytologiste preparait les lames immediatement apres la cytoponction, mais
personne ne realisait d’examen microscopique pour evaluer la conformite de l’echantillon et determiner le nombre de passages a effectuer. Les
rapports de cytopathologie ont ensuite ete classifies selon qu’ils presentaient des echantillons insatisfaisants ou satisfaisants a des fins
diagnostiques, les echantillons satisfaisants menant surtout a des diagnostics de nature benigne, maligne et indeterminee.
Resultats : Soixante-dix-sept biopsies ont ete prelevees en un passage, 124 en deux passages et 51 en trois passages. Les taux de biopsies
insatisfaisantes s’elevaient a 33,8 %, a 23,4 % (rapport de cotes de 0,599 [intervalle de confiance de 95 %, de 0,319 a 1,123]; P ¼ 0,110) et a
13,7 % (rapport de cotes de 0,312 [intervalle de confiance de 95 %, de 0,124 a 0,788]; P ¼ 0,014) respectivement.* Address for correspondence: Cyrille Na€ım, MD, Department of Radi-
ology, Ho^pital Jean-Talon (CSSS du Coeur-de-l’Ile), 1385 Rue Jean-Talon
Est, Montreal, Quebec H2E 1S6, Canada.
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taux d’echantillons satisfaisants de 20 % par rapport a la methode a un passage, affiche un resultat semblable a celui indique dans la
documentation et constitue un premier pas vers l’amelioration de nos pratiques.
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Key Words: Fine-needle aspiration cytology; Thyroid biopsy; ultrasound-guidedThe prevalence of thyroid nodules in the general pop-
ulation is 4%-7% [1]; among these, approximately 5% are
thyroid carcinomas [2]. Thyroid fine-needle aspiration
cytology (FNAC) is the most accurate diagnostic procedure
used to differentiate benign from malignant thyroid nodules
[3] and is widely used by radiologists, surgeons, endocri-
nologists, and pathologists. Despite its accuracy in correctly
identifying malignancy, the rate of unsatisfactory samples
remains elevated in many practice settings, sometimes
beyond 20%. Thus, it results in repeated biopsies, patient
anxiety, and unnecessary surgeries. Recommendations differ
among institutions in terms of the many factors that can
affect the sample adequacy rate, such as ultrasound (US) vs
palpation guidance, needle size, number of needle passes,
requirement of on-site microscopic evaluation by a patholo-
gist, preparation methods of cytology samples, and cytopa-
thology reporting definitions [3]. To decrease the risk of
scant or hypocellular unsatisfactory samples, the National
Cancer Institute recommends performing 2-5 needle passes
by using a 22- to 27-gauge needle and advises centers to have
an efficient cooperation between the physician performing
the biopsy and the cytopathology department to optimize
proper preparation of slides and provide on-site microscopic
evaluation of specimen adequacy [4]. The use of US guid-
ance has been validated [5e7]; the presence of an on-site
pathologist has been debated [8e10]; and the choice of
needle size, number of passes, and aspiration or capillary
technique frequently vary from one institution to another.
The procedural technique is highly dependent on operator
preference, available resources, and influence of other factors
present. For these reasons, thyroid FNAC practice is not
standardized worldwide. Because our clinical setting, among
many others, does not have available resources for on-siteTable 1
Classification system for thyroid fine-needle aspiration cytology reports
Cytopathology category Cytopatho
Unsatisfactory (or inadequate) sample Hypocellu
or stain
Positive or suspicious for malignancy Presence o
pseudoi
characte
Undetermined diagnosis Could be
diagnos
Benign
Benign hyperplastic nodule (goiter) Follicular
Benign thyroiditis Presence o
Benign cyst Normal fo
Benign, other Atrophy, n
a From Refs. 13e15.microscopic examination by a pathologist to guide the
number of needle passes, we sought to evaluate and improve
our practice. In this retrospective observational study, we
examined our thyroid US-guided fine-needle aspiration
biopsy technique; we determined which factors affected our
adequacy rates, particularly, the number of needle passes and
needle size; we compared our results to the literature; and we
established recommendations for optimal technique in our
practice and in that of other clinics with similar settings.
Materials and Methods
This study was approved by our institution’s research and
ethics committee; patient informed consent for the review of
medical records and images was not required. A retrospec-
tive review was performed for all ultrasound-guided FNACs
performed by a single experienced radiologist (D.E. [with 10
years’ experience]) at our hospital’s radiology department
between January 1, 2005, and September 30, 2010. Patients
were referred for FNAC by their primary care physician or
specialist within the Montreal region. Cytopathology reports
for every biopsy were collected and classified according to
the results of the report: an unsatisfactory (inadequate) or
a satisfactory sample for analysis, the latter consisted of
benign, malignant, and undetermined diagnosis (Table 1).
Information was recorded on the year of biopsy, the number
of needle passes for each biopsy, and the number of needle
pass samples that were satisfactory. All the samples were
evaluated and signed by the pathologists at our institution.
By using a 13-MHz real-time US scanner (Toshiba Aplio
XG, SSA-790, Tochigi-ken, Japan), the thyroid lesion was
identified and characterized. The patient’s anterior neck was
locally sterilized with povidone-iodine and was anesthetizedlogy definition
lar (<6 groups of 10-20 follicular cells)a, poor fixation
ing, drying artifact, or blood obscuring cells
f characteristics suggestive of malignancy (intranuclear cytoplasmic
nclusions, psammoma bodies, etc). Hypocellular samples with malignancy
ristics fit under this category.
either benign or malignant: there is enough cellular material, but accurate
is cannot be made. Examples include follicular and H€urthle cell neoplasms.
epithelial hyperplasia with variable colloid content
f lymphocytes
llicular cells and cystic structure
ormal follicular cells, absence of atypia or neoplasia
Figure 1. Prevalence of each fine-needle aspiration cytopathology result.
Figure 2. Number of biopsies per year. There is a decrease in the use of 1
needle pass over time.
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a 10-mL syringe was used. The needle tip and thyroid nodule
were visualized with real-time US during the procedure. The
needle was targeted to areas assumed to contain the most
cellular material, such as the solid or noncentral parts of
a vascular nodule or cyst [11]. Continuous low suction
pressure was applied simultaneously with to-and-fro move-
ments of the needle within the lesion until material was seen
in the needle hub. Suction was slowly released before needle
removal from the lesion. From January 2005 to December
2009, this procedure was performed with either 1 or 2 needle
passes. There were no specific criteria for choosing 1 or
2 needle passes, but there was an increase in the use of
2 needle passes over time because of an observed decline in
unsatisfactory rate in comparison with 1 needle pass. Starting
on January 1, 2010, all FNACs were performed exclusively
with 3 needle passes and a 25-gauge needle. Each FNAC
procedure required an average time of 2, 3, or 4 minutes for
1, 2, or 3 needle passes, respectively. At the end of the
procedure, manual compression was applied for 10 minutes
at the site of biopsy. All the patients were observed for
30 minutes after the biopsy and were informed of the
possible signs and symptoms of hematoma.
For all FNACs, a cytology technician was present on-site
to prepare slides as soon as specimens were drawn, and
identified them as first, second, or third pass. The goal of this
quick preparation was to prevent sample inadequacy from
drying, artifact, or poor fixation. There was no on-site
microscopic assessment. The contents of the syringe were
smeared onto unpolished glass slides, ethyl alcohol cytology
fixative was immediately applied, and the slides were sent to
the cytology department, where Papanicolaou staining was
used for microscopic analysis. Any remaining residue or
bloody samples were rinsed and collected with normal saline
solution for cell block analysis, which consisted of centri-
fugation, sediment collection, and repeated suspension in an
alcohol fixative for a second and final centrifugation and for
sediment collection. Each cell block analysis provided
a complementary report to the final cytopathology report.
Statistical analyses were performed with IBM SPSS
Statistics Standard software, version 19 (IBM Corp, Armonk,
NY). Associations among needle size, number of needle
passes, and satisfactory samples were determined by Pearson
c2 and univariate logistic regression analyses to obtain odds
ratios.
Results
A total of 252 biopsy reports from January 1, 2005, until
September 30, 2010, were collected for 220 patients. The
prevalence of each biopsy result is shown in Figure 1. One-
hundred and ninety were satisfactory biopsy samples
(75.4%), and 62 were unsatisfactory (24.6%). Seventy-seven
biopsies (30.6%) were performed with 1 needle pass,
124 with 2 needle passes (49.2%), and 51 with 3 needle
passes (20.2%). The number of biopsies performed and the
sample inadequacy rate per year are shown in Figures 2 and3. Inadequacy rates and ORs for each method are presented
in Table 2. By using the 1 needle pass technique as the
reference, the OR for an inadequate sample by 2 needle
passes and a 22-gauge needle was 0.599 (95% confidence
interval [CI], 0.319-1.123; P ¼ .110) and that by 3 needle
passes and a 25-gauge needle was 0.312 (95% CI,
0.124-0.788; P ¼ .014). When comparing with 2 needle
passes, the inadequacy rate with 3 passes diminished with an
OR of 0.521, however, it was not statistically significant
(95% CI, 0.212-1.281; P ¼ .156). A Pearson c2 test for the
association between needle size alone and inadequacy rate
showed a decrease in inadequacy rate, from 27.4% to 13.7%
with the use of 25-gauge needles (OR 0.422 [95% CI,
0.179-0.994]; P ¼ .043).
Of the 95 satisfactory biopsies performed with the 2 needle
pass method, 34 had 1 of 2 samples satisfactory for diagnosis
(35.8%), and 61 had both samples satisfactory (64.2%). Of the
44 satisfactory biopsies performed with 3 needle passes, 12
had 1 of 3 satisfactory samples (27.3%), 7 had 2 satisfactory
samples (15.9%), 16 had 3 satisfactory samples (36.4%), and
9 had an unknown number of satisfactory samples (20.5%)
(missing values due to provisional reporting modifications).
Cell block analysis was performed in 136 biopsies (54%) and
provided sample adequacy when cytology alone could not in
9 FNACs (4.7% of all 190 satisfactory biopsies). None of the
patients developed complications after the biopsy procedure.
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Figure 3. Fine-needle aspiration cytology (FNAC) inadequacy rates per year.
Two- and 3-needle pass methods have a lower inadequacy rate than a 1-
needle pass method. This figure is available in colour online at http://
carjonline.org/.
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Many studies have addressed the issue of inadequate
thyroid FNAC specimens by examining a variety of factors
that affect adequacy rate [4,10]. However, in clinics that do
not have an on-site pathologist to assess specimen adequacy,
physicians who perform thyroid FNACs still face a dilemma
when choosing the number of needle passes to perform.
Although guidelines are relatively flexible and the procedural
technique varies worldwide, the ultimate goal is the same: to
decrease the sample inadequacy rate and to optimize patient
care and cost-effectiveness. We believe that a valuable
approach to achieve this goal for any physician who practices
thyroid FNACs is to observe recommendations and the
literature, evaluate his or her inadequacy rates, and improve
his or her technique where possible. Our study is based on
this approach.
This study demonstrates that, in our current practice
setting without on-site microscopic examination by
a pathologist, 3 passes with a 25-gauge needle decrease the
sample inadequacy rate by 20.1% compared with 1 pass with
a 22-gauge needle, and halve the inadequacy rate compared
with a 22-gauge needle with 1 or 2 passes. These results offer
a better understanding of how to further improve adequacy
rates in a practice without an on-site microscopic
examination.Table 2
Unsatisfactory fine-needle aspiration thyroid biopsy rates, 2005-2010
Needle
size (gauge) No. passes
Unsatisfactory
biopsies
Satisfactory
biopsies
22 1-pass 26 51
22 2-pass 29 95
25 3-pass 7 44
Total 62 190
OR¼ odds ratio.
a Statistically significant.
b Compared to 1-pass.
c Compared to 2-pass.The methodology of this study provided us with the
ability to appropriately compare our results to those of other
published studies. The reporting of cytology results of
thyroid FNAC is highly variable from one institution to
another, with inconsistent definitions and differing numbers
of diagnosis categories [12]. In spite of this, pathologists at
our institution have consistently identified inadequate
samples based on widely accepted definitions [13e15] and
used clear reporting categories. Moreover, our sample pop-
ulation consisted of consecutive reports studied within
a defined period and had an incidence of suspicious or
malignant nodules comparable with the literature [2,16];
thus, it is likely representative of the general North American
urban population usually referred for a thyroid FNAC.
The presence of an on-site specimen adequacy assessment
by a pathologist was cost effective in a study by Nasuti et al
[8] but time consuming and counterproductive in a study by
O’Malley [9]. In the present study without on-site cytology
evaluation, the inadequacy rate was 13.7%, comparable with
reported rates of 10%-20% in the literature [5,17e23], which
suggests that the presence of on-site cytology evaluation for
sample adequacy is not necessary to achieve low inadequacy
rates.
The main limitation of this study was its inability to assess
the individual effect of 3 passes or 25-gauge needle size on
the inadequacy rate because both of these variables were
combined into a single technique, which proved to be
significantly more effective. This must be carefully inter-
preted in context. In general, results of some studies
demonstrated lower inadequacy rates with an increase in the
number of passes, but, beyond 5 or 6 passes, the inadequacy
rate stabilized between 2% and 5% [10,17]. In addition,
conflicting opinions exist on the advantage of using smaller
needles (25 or 27 gauge). Some researchers suggest that they
decrease the risk of pain and hemorrhagic specimens [24],
whereas other researchers suggest that larger 21-gauge nee-
dles provide more specimen cellularity but may not signifi-
cantly change sample adequacy rate [18,25]. Finally,
a greater number of biopsies performed with 3 passes would
have improved the reliability of our results.
Cell block analysis contributed to the sample adequacy in
4.7% of satisfactory cases, but it was not performed for all
biopsies; thus, we could not assess its individual effect on the
inadequacy rate. Sanchez and Selvaggi [26] did not find cellTotal no.
biopsies
Inadequacy
rate, % ORb (P value) ORc (P value)
77 33.8 1.00
124 23.4 0.599 (.110) 1.00
51 13.7 0.312a (.014) 0.521 (.156)
252 24.6
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Qiu et al [27] found that cell block significantly decreased
the inadequacy rate in hemorrhagic samples.
A number of previously reported confounding variables
were not controlled, such as the type and size of thyroid
nodules, reason for inadequacy (hemorrhage vs hypo-
cellularity), and surgical pathology diagnosis. Our goal was
not to pinpoint individual contribution to sample inadequacy
by each variable or to design a multivariate analysis but rather
to evaluate our practice and propose solutions to increase our
rate of sample adequacy based on available resources. We
determined that the most easily modifiable factors in our
setting include needle size, number of needle passes, suction
or capillary technique, and use of cell block analysis.
Currently, appropriate sample adequacy rates are achieved
with 3 passes and a 25-gauge needle size; however, based on
both our results and the literature, there is area for added
improvement. In particular, the number of passes could be
increased, with a minimum of 3, up to a maximum of
6 passes. The main drawbacks include an increase in
procedure time and in the pathologist’s workload. Otherwise,
thyroid FNAC is generally well-tolerated by patients, with
rare and minor complications, most commonly that involve
a small hematoma or local pain [28,29]. A 25-gauge needle
size should continue to be used to decrease the risk of
hemorrhagic samples. On-site proper smearing and fixation
of samples is necessary to avoid drying artifacts. Cell block
analysis for any residual material should continue to
complement cytology, especially for hemorrhagic-prone
samples. A common alternative to conventional smears is
the use of liquid-based cytology; however, its efficacy in
decreasing inadequacy rates for thyroid FNAC is still
debated [30,31], and introducing this technique involves
significant changes in pathology practice [4]. Results of
some studies demonstrated that the capillary technique does
not significantly change the adequacy rate compared with the
suction technique [32e34], whereas results of other studies
suggested that capillary technique decreases hemorrhagic
samples [35,36], could be beneficial for biopsy of vascular
nodules [23], and tends to be easier and quicker to use [34].
Because both techniques are widely accepted [37], the choice
of either technique in our setting should be based on operator
preference. Finally, an on-site microscopic assessment could
potentially decrease inadequacy rates but is not necessary for
now; the effect of further technical improvements and time
constraints must be evaluated in our radiology department
before committing to such a modification.
In conclusion, in the absence of an on-site pathologist for
specimen adequacy assessment, modifying our technique to
3 needle passes with a 25-gauge needle size has significantly
decreased our sample inadequacy rate to 13.7%, which is
comparable with the literature and provided a basis for
further improvement of our practice. Based on our results
and the literature, our recommendations for further
improvement are useful for any thyroid FNAC practice
setting that does not have an on-site pathologist’s micro-
scopic assessment.Acknowledgements
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